Soulban G, Labrecque G, Bélanger P M
Ecole de pharmacie, Université Laval, Québec, Canada.
Chronobiol Int. 1990;7(5-6):403-11. doi: 10.3109/07420529009059151.
In this in vivo study, the time-dependent effect of oral sodium warfarin was studied in male rats synchronized under a 12-hr light-dark cycle (light 0600-1800). Groups of 5 animals received an oral dose of 500 micrograms/kg of warfarin or saline at 0600 or 1800 and 1 mg/kg of vitamin K 8 hr later and the rats were sacrificed 240 min after vitamin K administration. The activities of the vitamin K reductase and vitamin K epoxide reductase were measured indirectly by determining the content of vitamin K1 and vitamin K epoxide reductase in the plasma and liver. The data obtained in control rats indicated that vitamin K and vitamin K 2,3 epoxide concentrations in plasma and liver were higher (P less than 0.05) at 1800 than at 0600. Warfarin had a greater (P less than 0.05) inhibitory effect on the vitamin K and vitamin K-epoxide reductases at 0600 compared to 1800; plasma levels of S- and R-warfarin did not vary with time of administration. The findings suggest that the activity of both reductases under control conditions, and the warfarin-induced inhibition of these enzymes varied depending on the time of drug administration.
在这项体内研究中,研究了口服华法林钠在12小时明暗循环(光照时间为06:00 - 18:00)同步饲养的雄性大鼠中的时间依赖性效应。每组5只动物在06:00或18:00口服500微克/千克的华法林或生理盐水,8小时后给予1毫克/千克的维生素K,在给予维生素K后240分钟处死大鼠。通过测定血浆和肝脏中维生素K1和维生素K环氧化物还原酶的含量间接测量维生素K还原酶和维生素K环氧化物还原酶的活性。在对照大鼠中获得的数据表明,血浆和肝脏中维生素K和维生素K 2,3环氧化物的浓度在18:00时高于06:00(P < 0.05)。与18:00相比,华法林在06:00对维生素K和维生素K环氧化物还原酶的抑制作用更强(P < 0.05);S - 和R - 华法林的血浆水平不随给药时间而变化。这些发现表明,在对照条件下两种还原酶的活性以及华法林诱导的对这些酶的抑制作用随给药时间而变化。